Clinical Research Directory
Browse clinical research sites, groups, and studies.
Long Term Follow-Up for Safety of AVR-RD-02
Sponsor: John Bernat
Summary
The goal of this observational study is to assess the safety and tolerability of AVR-RD-02 treatment in subjects who previously received AVR-RD-02 treatment (single dose administration).
Official title: A Long-Term Follow-Up Safety Study of Subjects With Gaucher Disease Who Previously Received AVR-RD-02
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
2
Start Date
2024-02-21
Completion Date
2037-10
Last Updated
2025-07-22
Healthy Volunteers
No
Conditions
Interventions
AVR-RD-02
No study drug is administered in this study. Subjects who received AVR-RD-02 in a separate parent trial will be evaluated in this trial for long-term safety.
Locations (1)
University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States